Amid efforts to expand naloxone access, a controversial new study questions its value
(By Lev Facher for STAT) WASHINGTON — Amid a worsening opioid epidemic, the overdose-reversal drug naloxone has taken center stage.
Read More(By Lev Facher for STAT) WASHINGTON — Amid a worsening opioid epidemic, the overdose-reversal drug naloxone has taken center stage.
Read More(By Helen Branswell for STAT) The sole influenza vaccine made in cell culture in the United States may have worked
Read More(By Brian Zimmerman for Becker’s Hospital Review) Kentucky’s Attorney General on March 8 filed a lawsuit against AmerisourceBergen, alleging the
Read More(By Morgan Haefner for Becker’s Hospital Review) Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and
Read More(By Jenny Gold for Kaiser Health News) YUBA CITY, Calif. — When Landon Morris was diagnosed with hemophilia shortly after
Read More(By Ike Swetlitz for STAT) WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb said that it’s not his agency’s
Read More(By Alex Smith, KCUR for Kaiser Health News) A few years ago, Renea Molden’s doctors told her they wanted to
Read More(By Lev Facher for STAT) WASHINGTON — In the final hours of public input on a controversial new rule limiting
Read More(By Barbara Feder Ostrov for California Healthline produced by Kaiser Health News) The child is well-known in the halls where
Read More(By Andrew Joseph for STAT) Lawmakers in Kentucky are weighing whether to impose a new tax on opioid prescriptions, the
Read More